Boya BioTech (300294.SZ) appointed Vice President Ren Hui as President.

Smart Finance News APP, Boya Biology (300294.SZ) announced that the company's board of directors received written resignation reports from Liang Xiaoming and Liang Huacheng on May 16, 2025. Due to changes in work, Liang Xiaoming applied to resign as the company's CEO and legal representative, and Liang Huacheng applied to resign as the company's CFO. After resigning as CEO and legal representative, Liang Xiaoming will continue to serve as a director of the eighth board of directors and a member of the Strategy and ESG Committee of the eighth board of directors of the company; after resigning as CFO, Liang Huacheng will continue to serve as a director of the eighth board of directors, vice president, and board secretary of the company.